Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 54.18-2.417.3270.7146.60

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 54.18 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202554.18
Mar2024-2.41
Mar20237.32
Mar202270.71
Mar202146.60

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 54.18
Positive
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71
51.74
Mar2021 46.6 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,936.1 Cr -1.6% 1% 12.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.6%

1%

12.7%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses